Announcements Trials
Browse Landscape

Phase

Phase NA 7Phase 2 4Phase 3 2Phase 4 1Phase 1/2 1Phase 1 1

Status

Completed 3Recruiting 1

Sponsor Class

OTHER 228INDUSTRY 68NIH 44NETWORK 24OTHER_GOV 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4

Conditions

Breast Neoplasms 55Carcinoma, Non-Small-Cell Lung 33Stomach Neoplasms 28Colorectal Neoplasms 26Small Cell Lung Carcinoma 19Lung Neoplasms 18Rectal Neoplasms 16Pancreatic Neoplasms 14Neoplasms 14Neoplasm Metastasis 14Uterine Cervical Neoplasms 12Esophageal Neoplasms 12Ovarian Neoplasms 11Nasopharyngeal Carcinoma 11Carcinoma, Hepatocellular 11Recurrence 10Leukemia, Myeloid, Acute 10Melanoma 9Esophageal Squamous Cell Carcinoma 8Colonic Neoplasms 8Triple Negative Breast Neoplasms 7Lymphoma, Non-Hodgkin 7Head and Neck Neoplasms 7Hodgkin Disease 6Cholangiocarcinoma 6Adenocarcinoma of Lung 6Squamous Cell Carcinoma of Head and Neck 5Prostatic Neoplasms 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Neoplasms, Germ Cell and Embryonal 5

Interventions

Gemcitabine 2toripalimab 1Mitomycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × OTHER_GOV × Urinary Bladder Neoplasms × Clear all
NCT06388720 2026-05-29

IMGeS

National Cancer Center, Korea

Phase 2 Recruiting
82 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT04553939 2026-01-02

Neoadjuvant Toripalimab in Combination With Gemcitabine Therapy in Cisplatin Ineligible Local Advanved Bladder Cancer

Henan Cancer Hospital

Phase 2 Completed
50 enrolled
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT03058757 2023-01-31

The Effectiveness and Safety of Neoadjuvant Intravesical Mitomycin-C Instillation

National Cancer Center, Korea

Phase 2 Completed
71 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT04184232 2021-01-22

Treatment of Recurrent Bladder Cancer With Dendritic Cells

Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus

Phase 2 Completed
17 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡